{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:55:38Z","timestamp":1791338138908,"version":"4.3.1"},"reference-count":34,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Background: The aim of the present work was to analyze a 10-year retrospective series of surgically treated medication-related osteonecrosis of the jaws (MRONJ) cases, reporting the clinical outcome and success rate for each adopted procedure in order to draw a treatment algorithm that is able to standardize clinical decision making and maximize the success of oral surgical treatment of MRONJ. Methods: Different surgical approaches were categorized taking into consideration two variables (a) hard tissue management (defined as debridement, saucerization or marginal resective surgery of maxillary necrotic bone) and (b) soft tissue management (defined as type of flap design and related modality of wound-healing). Results: For the retrospective cohort study, 103 MRONJ patients were enrolled and a total of 128 surgical procedures were performed. The role of radical-intended surgery using local flaps in MRONJ treatment was investigated, as well as palliative treatments. All stage I\u2013II patients completely healed when a combination of radical necrotic bone surgery associated with a first intention healing of soft tissues was obtained. In stage III, when a patient was not eligible for maxillo-facial surgery, the use of palliative surgical strategies was effective in symptom relief in order to maintain a better quality of life for the duration of the patient\u2019s life. Conclusions: Oral surgery with radical intent associated with a flap design able to ensure first intention healing might represent a valid option for the majority of MRONJ patients. The designed decision tree allows clinicians to assess individual surgical approaches for MRONJ treatment in accordance with patient-centered outcomes and surgical skills.<\/jats:p>","DOI":"10.3390\/life10070099","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T11:17:17Z","timestamp":1593429437000},"page":"99","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Oral Surgical Management of Bone and Soft Tissues in MRONJ Treatment: A Decisional Tree"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5664-3118","authenticated-orcid":false,"given":"Antonia","family":"Marcian\u00f2","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erasmo","family":"Rubino","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6995-6276","authenticated-orcid":false,"given":"Matteo","family":"Peditto","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4008-6502","authenticated-orcid":false,"given":"Rodolfo","family":"Mauceri","sequence":"additional","affiliation":[{"name":"Department of Surgical, Oncological and Oral Sciences, University of Palermo, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0941-1645","authenticated-orcid":false,"given":"Giacomo","family":"Oteri","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","article-title":"Antiresorptive agent-related osteonecrosis of the jaw: Position paper 2017 of the Japanese allied committee on osteonecrosis of the jaw","volume":"35","author":"Yoneda","year":"2016","journal-title":"J. Bone Miner. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.joms.2016.12.014","article-title":"Extensive surgical procedures result in better treatment outcomes for bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis","volume":"75","author":"Kim","year":"2017","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Beth-Tasdogan, N.H., Mayer, B., and Hussein, H. (2016). Interventions for managing medication-related osteonecrosis of the jaw (MRONJ). Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD012432"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","article-title":"The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw","volume":"111","author":"Wilde","year":"2011","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1097\/SCS.0000000000006288","article-title":"Role of local flaps to achieve primary wound closure in medication-related osteonecrosis of the jaws osseous-resective surgery","volume":"31","author":"Peditto","year":"2020","journal-title":"J. Craniofacial Surg."},{"key":"ref_7","unstructured":"Ministero Della Salute, Agenzia Italiana del Farmaco (AIFA) (2017, March 27). Circolare AIFA del 3 Agosto 2007. Linee Guida per la Classificazione e Conduzione Degli Studi Osservazionali Sui Farmaci, Available online: http:\/\/xoomer.virgilio.it\/pgiuff\/osservazionali.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1601-0825.2012.01903.x","article-title":"Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"18","author":"Bedogni","year":"2012","journal-title":"Oral Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bjoms.2014.04.009","article-title":"Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease","volume":"52","author":"Bedogni","year":"2014","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40264-017-0582-6","article-title":"Treatment of medication-related osteonecrosis of the jaw and its impact on a patient\u2019s quality of life: A single-center, 10-year experience from southern Italy","volume":"41","author":"Oteri","year":"2017","journal-title":"Drug Saf."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00784-017-2325-6","article-title":"Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: A systematic review and meta-analysis of the drug suspension protocol","volume":"22","author":"Ramaglia","year":"2018","journal-title":"Clin. Oral Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.joms.2008.12.057","article-title":"Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: Review of 33 surgical cases","volume":"67","author":"Stanton","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.oooo.2012.05.017","article-title":"Intravenous bisphosphonate\u2013related osteonecrosis of the jaw: Long-term follow-up of 109 patients","volume":"115","author":"Watters","year":"2013","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jcms.2018.03.005","article-title":"Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw A single center cohort study","volume":"46","author":"Ristow","year":"2018","journal-title":"J. Cranio Maxillofac. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.oooo.2016.03.008","article-title":"Evaluation of a surgical treatment of denosumab-related osteonecrosis of the jaws","volume":"122","author":"Pichardo","year":"2016","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.joms.2012.05.019","article-title":"Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: A retrospective survey of 347 cases","volume":"70","author":"Graziani","year":"2012","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.oraloncology.2011.11.004","article-title":"The saxon bisphosphonate register\u2014Therapy and prevention of bisphosphonate-related osteonecrosis of the jaws","volume":"48","author":"Schubert","year":"2012","journal-title":"Oral Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.oraloncology.2011.02.024","article-title":"Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis","volume":"47","author":"Bedogni","year":"2011","journal-title":"Oral Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00520-009-0688-1","article-title":"Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: A prospective clinical study with 12 months follow-up","volume":"18","author":"Stockmann","year":"2009","journal-title":"Support. Care Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00784-011-0596-x","article-title":"Bisphosphonate-associated osteonecrosis of the mandible: Reliable soft tissue reconstruction using a local myofascial flap","volume":"16","author":"Lemound","year":"2011","journal-title":"Clin. Oral Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3892\/or_00000837","article-title":"Immunohistochemial evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw","volume":"24","author":"Favaloro","year":"2010","journal-title":"Oncol. Rep."},{"key":"ref_23","first-page":"E1","article-title":"Impact of integrated treatments on patient management in solid tumors: From diagnosis to palliative care","volume":"14","author":"Adamo","year":"2006","journal-title":"Forum"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joms.2014.07.012","article-title":"Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: A pooled case report analysis","volume":"73","author":"Hinson","year":"2015","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jcms.2017.01.013","article-title":"Clinical course and therapeutic outcomes of operatively and non-operatively managed patients with denosumab-related osteonecrosis of the jaw (DRONJ)","volume":"45","author":"Hoefert","year":"2017","journal-title":"J. Cranio Maxillofac. Surg."},{"key":"ref_26","unstructured":"(2020, May 27). Banca Dati Farmaci Dell\u2019AIFA, Available online: https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_002317_040108_RCP.pdf&retry=0&sys=m0b1l3."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jcms.2017.05.027","article-title":"The impact of surgical intervention and antibiotics on MRONJ stage II and III\u2014Retrospective study","volume":"45","author":"Zirk","year":"2017","journal-title":"J. Cranio Maxillofac. Surg."},{"key":"ref_28","first-page":"907","article-title":"Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws","volume":"137","author":"Koschinski","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10006-016-0597-7","article-title":"Treatment of medication-related osteonecrosis of the jaws (MRONJ) with ultrasonic piezoelectric bone surgery. A case series of 20 treated sites","volume":"21","author":"Blus","year":"2016","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10006-015-0538-x","article-title":"Surgical management of bisphosphonate-related osteonecrosis of the jaws: Literature review","volume":"20","author":"Silva","year":"2015","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.joms.2017.09.021","article-title":"Nasolabial flap improves healing in medication-related osteonecrosis of the jaw","volume":"76","author":"Lemound","year":"2018","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.joms.2014.09.023","article-title":"Pedicled buccal fat pad flap as a reliable surgical strategy for the treatment of medication-related osteonecrosis of the jaw","volume":"73","author":"Rotaru","year":"2015","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","article-title":"Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: A report of 32 cases","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/jbmr.3237","article-title":"Short-term teriparatide and recombinant human bone morphogenetic protein-2 for regenerative approach to medication-related osteonecrosis of the jaw: A preliminary study","volume":"32","author":"Jung","year":"2017","journal-title":"J. Bone Miner. Res."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/10\/7\/99\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:44:42Z","timestamp":1760175882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/10\/7\/99"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["life10070099"],"URL":"https:\/\/doi.org\/10.3390\/life10070099","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]}}}